Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 15:10:2021-7-5.
doi: 10.7573/dic.2021-7-5. eCollection 2021.

COVID-19-related adaptations to the implementation and evaluation of a clinic-based intervention designed to improve opioid safety

Affiliations
Review

COVID-19-related adaptations to the implementation and evaluation of a clinic-based intervention designed to improve opioid safety

Anna R Morgan et al. Drugs Context. .

Abstract

The United States faces an opioid crisis with an unprecedented and increasing death rate from opioid overdose. Successfully reducing the rates of opioid use disorder (OUD) and overdose will require the engagement of frontline clinicians to prescribe opioids more safely and to build their capacity to treat patients with OUD using evidence-based approaches. The COVID-19 pandemic has created significant challenges for patients, clinicians and health systems and has been associated with increasing risks of overdoses and deaths. Herein, we review a multidisciplinary project designed to implement and evaluate clinic-based interventions in Oregon, USA, to improve pain management, opioid prescribing and treatment of OUD. The intervention, called Improving PaIn aNd OPiOId MaNagemenT in Primary Care (PINPOINT), combines practice facilitation, academic detailing and education through the Oregon ECHO Network. Implementation of PINPOINT has occurred across the Oregon Rural Practice-based Research Network and has involved 49 clinic sites to date. To evaluate the impact of the intervention, the research team created the Provider Results of Opioid Management and Prescribing Training (PROMPT), a dataset that links information from the state prescription drug monitoring program, all-payer claims database, emergency medical services, vital records and substance use disorder treatment system. The PROMPT dataset will allow evaluation of the impact of the intervention at both the clinician and clinic levels. Due to the constraints of the COVID-19 pandemic, elements of both implementation and evaluation required significant adaptations to continue to meet the original project goals.

Keywords: academic detailing; all-payer claims database; opioid safety; practice facilitation; prescription drug monitoring programs.

PubMed Disclaimer

Conflict of interest statement

Disclosure and potential conflicts of interest: MAF serves as a clinical consultant for Alosa Health, an educational non-profit that provides academic detailing services, and directs the National Resource Center for Academic Detailing, a program within the Division of Pharmacoepidemiology and Pharmacoeconomics. NaRCAD is funded by grants from AHRQ (R18HS026177 and R13HS026829) and contracts from the CDC and NACCHO. The International Committee of Medical Journal Editors (ICMJE) Potential Conflicts of Interests form for the authors is available for download at: https://www.drugsincontext.com/wp-content/uploads/2021/10/dic.2021-7-5-COI.pdf

Figures

Figure 1
Figure 1
PROMPT linkage methodology. APCD, All Payer All Claims dataset; DEA, Drug Enforcement Agency; DOB, date of birth; IVPP, Injury and Violence Prevention Program; NPI, National Provider Identifier; PCP, primary care provider; PDMP, Prescription Drug Monitoring Program.

References

    1. Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths – United States, 2013–2017. MMWR Morb Mortal Wkly Rep. 2019;67:1419–1427. doi: 10.15585/mmwr.mm675152e1. - DOI - PMC - PubMed
    1. Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559–574. doi: 10.1146/annurev-publhealth-031914-122957. - DOI - PubMed
    1. Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths--United States, 2000–2014. MMWR Morb Mortal Wkly Rep. 2016;64(50–51):1378–1382. doi: 10.15585/mmwr.mm6450a3. - DOI - PubMed
    1. Guy GP, Jr, Zhang K, Schieber LZ, Young R, Dowell D. County-level opioid prescribing in the United States, 2015 and 2017. JAMA Intern Med. 2019;179(4):574–576. doi: 10.1001/jamainternmed.2018.6989. - DOI - PMC - PubMed
    1. Friedman J, Kim D, Schneberk T, et al. Assessment of racial/ethnic and income disparities in the prescription of opioids and other controlled medications in California. JAMA Intern Med. 2019;179(4):469–476. doi: 10.1001/jamainternmed.2018.6721. - DOI - PMC - PubMed